190 related articles for article (PubMed ID: 23555694)
1. Optimizing treatment regimes to hinder antiviral resistance in influenza across time scales.
Patterson-Lomba O; Althouse BM; Goerg GM; Hébert-Dufresne L
PLoS One; 2013; 8(3):e59529. PubMed ID: 23555694
[TBL] [Abstract][Full Text] [Related]
2. The effect of population structure on the emergence of drug resistance during influenza pandemics.
Débarre F; Bonhoeffer S; Regoes RR
J R Soc Interface; 2007 Oct; 4(16):893-906. PubMed ID: 17609176
[TBL] [Abstract][Full Text] [Related]
3. Antiviral resistance and the control of pandemic influenza.
Lipsitch M; Cohen T; Murray M; Levin BR
PLoS Med; 2007 Jan; 4(1):e15. PubMed ID: 17253900
[TBL] [Abstract][Full Text] [Related]
4. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
[TBL] [Abstract][Full Text] [Related]
5. A comparative evaluation of modelling strategies for the effect of treatment and host interactions on the spread of drug resistance.
Alexander ME; Dietrich SM; Hua Y; Moghadas SM
J Theor Biol; 2009 Jul; 259(2):253-63. PubMed ID: 19344730
[TBL] [Abstract][Full Text] [Related]
6. Influenza virus resistance to antiviral therapy.
van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
[TBL] [Abstract][Full Text] [Related]
7. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
Dafilis MP; Moss R; McVernon J; McCaw J
Epidemics; 2012 Dec; 4(4):219-26. PubMed ID: 23351374
[TBL] [Abstract][Full Text] [Related]
8. Emergence of drug-resistant influenza virus: population dynamical considerations.
Regoes RR; Bonhoeffer S
Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
[TBL] [Abstract][Full Text] [Related]
9. The timing and targeting of treatment in influenza pandemics influences the emergence of resistance in structured populations.
Althouse BM; Patterson-Lomba O; Goerg GM; Hébert-Dufresne L
PLoS Comput Biol; 2013; 9(2):e1002912. PubMed ID: 23408880
[TBL] [Abstract][Full Text] [Related]
10. The global spread of drug-resistant influenza.
Chao DL; Bloom JD; Kochin BF; Antia R; Longini IM
J R Soc Interface; 2012 Apr; 9(69):648-56. PubMed ID: 21865253
[TBL] [Abstract][Full Text] [Related]
11. Intervention strategies for an influenza pandemic taking into account secondary bacterial infections.
Handel A; Longini IM; Antia R
Epidemics; 2009 Sep; 1(3):185-95. PubMed ID: 20161493
[TBL] [Abstract][Full Text] [Related]
12. Optimality of a time-dependent treatment profile during an epidemic.
Jaberi-Douraki M; Moghadas SM
J Biol Dyn; 2013; 7(1):133-47. PubMed ID: 23859002
[TBL] [Abstract][Full Text] [Related]
13. Modeling the effects of drug resistant influenza virus in a pandemic.
Brockmann SO; Schwehm M; Duerr HP; Witschi M; Koch D; Vidondo B; Eichner M
Virol J; 2008 Oct; 5():133. PubMed ID: 18973656
[TBL] [Abstract][Full Text] [Related]
14. [High prevalence of antiviral resistant influenza, and reduced clinical effectiveness of the antivirals against resistant influenza strains].
Saito R
Jpn J Antibiot; 2010 Feb; 63(1):81-91. PubMed ID: 20836406
[No Abstract] [Full Text] [Related]
15. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details.
Handel A; Longini IM; Antia R
J Theor Biol; 2009 Jan; 256(1):117-25. PubMed ID: 18952105
[TBL] [Abstract][Full Text] [Related]
16. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
17. Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
McCaw JM; Wood JG; McCaw CT; McVernon J
PLoS One; 2008 Jun; 3(6):e2362. PubMed ID: 18523549
[TBL] [Abstract][Full Text] [Related]
18. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
19. Management of drug resistance in the population: influenza as a case study.
Moghadas SM
Proc Biol Sci; 2008 May; 275(1639):1163-9. PubMed ID: 18270154
[TBL] [Abstract][Full Text] [Related]
20. Emergence of drug resistance during an influenza epidemic: insights from a mathematical model.
Stilianakis NI; Perelson AS; Hayden FG
J Infect Dis; 1998 Apr; 177(4):863-73. PubMed ID: 9534957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
